EC Number |
Inhibitors |
Structure |
---|
2.3.2.B14 | (4R,5S,6S)-3-[[(3S,5R)-5-(aminomethyl)oxolan-3-yl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid |
compound identified by virtual screening, interacts with residues Arg242 and Gly304 |
|
2.3.2.B14 | (4R,6S)-3-[[(3R,5R)-5-(aminomethyl)oxolan-3-yl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid |
simulation of complex with isoform IprQ. The DELTAG# for the acylation is calculated as 24.29 kcal/mol |
|
2.3.2.B14 | (4R,6S)-3-[[(3R,5R)-5-(aminomethyl)oxolan-3-yl]sulfanyl]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid |
compound identified by virtual screening, interacts with residues Arg242 and Gly304 |
|
2.3.2.B14 | 2-[(2S,3S)-2-(2H-1,3-benzodioxol-5-yl)-1-(3-fluoro-4-methylphenyl)-4-oxoazetidin-3-yl]-5-nitro-1H-isoindole-1,3(2H)-dione |
inhibitor identified by virtual screening, demonstrates close hydrogen bond interaction between the ligand and two active site residues Asn303 and Cys305, shows the highest binding free energy observed |
|
2.3.2.B14 | 2-[(2S,3S)-2-(4-fluorophenyl)-1-(3-methylphenyl)-4-oxoazetidin-3-yl]-5-nitro-1H-isoindole-1,3(2H)-dione |
simulation of complex with isoform IprQ. The DELTAG# for the acylation is calculated as 20.9 kcal/mol |
|
2.3.2.B14 | 2-[(2S,3S)-2-(4-fluorophenyl)-1-(3-methylphenyl)-4-oxoazetidin-3-yl]-5-nitro-1H-isoindole-1,3(2H)-dione |
compound identified by virtual screening, interacts with the residue Asn263 and a water molecule which is within the active site |
|
2.3.2.B14 | 6-aminopenicillanic acid |
high degree of Cys354 modification, occurrence of a possible coupling reaction |
|
2.3.2.B14 | amoxicillin |
- |
|
2.3.2.B14 | amoxicillin |
no covalent adduct observed |
|
2.3.2.B14 | ampicillin |
- |
|